MedPath

A clinical trial on Ayurvedic formulation in the management of VatikaArtavadushti w.s.r. to Menstrual Disorder.

Phase 2
Conditions
Health Condition 1: N948- Other specified conditions associated with female genital organs and menstrual cycle
Registration Number
CTRI/2022/05/042352
Lead Sponsor
ATIONAL INSTITUTE OF AYURVEDA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients complaining of Vatika Artavadushti with any two of the following manifestations:

1. Artava vaivarnya (Discolored Menstrual Blood) - Aruna varna (Red/Reddish Brown/Tawny) or Shyava varna (Dark Brown) or Krishna varna (Black).

2. Alpa Artava (Hypomenorrhoea)

3. Vicchinna Artava (Interrupted flow)

4. Saruja Artava (Painful Menses)

5. Artava Chiraat Nishichyate (Oligomenorrhoea).

Female patients of age group 12 â?? 50 years.

Hb% >= 8 gm/dl.

Exclusion Criteria

1. Pregnant woman

2. Patient having any systemic disease.

3. Post menopausal woman.

4. Patient having any type of malignancy.

5. Patient having Sexually Transmitted Diseases.

6. Patient using oral contraceptive pills and Intra Uterine Contraceptive

Devices.

7. Patient with thyroid hormone abnormalities.

8. Patient having any other Uterine or Pelvic pathology like â?? Polyp,

Endometrial Tuberculosis, Fibroid, Adenomyosis, Pelvic

Inflammatory Diseases, etc.

9. Patients vaccinated for COVID-19 within three months.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Achievement of normal menstruation. <br/ ><br>Timepoint: 2 MONTHS <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Improvement in quality of life.Timepoint: 2 MONTHS
© Copyright 2025. All Rights Reserved by MedPath